Compare Kinder Morgan Inc (KMI) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Koninklijke Philips NV — how do they compare? Kinder Morgan Inc trades at $32.51 (market cap $72.48B), while Koninklijke Philips NV trades at $26.5 (market cap $26.19B). The key difference: Kinder Morgan Inc is far larger — about 2.8× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| KMI | PHG | |
|---|---|---|
Market Cap | $72.48B | $26.19B |
Sector | Energy | Health |
52-Week High | $34.31 | $32.91 |
52-Week Low | $25.84 | $24.54 |
Enterprise Value | $104.36B | $32.46B |
Dividend Yield | 3.61% | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $32.71, up 1.27% with neutral technical signals. The company shows strong fundamentals with revenue growth from $15.1B in 2024 to $16.9B in 2025 and net income margin improving to 18.04%. Recent Q1 2026 earnings beat expectations with $0.48 EPS versus $0.40 expected. KMI maintains a $10.1B project backlog focused on natural gas infrastructure, supporting future growth. Analyst sentiment is mixed with 47% buy ratings but technical indicators show neutral momentum near key support at $32.
KMI presents a balanced opportunity with stable cash flows from fee-based contracts and dividend yield near 4%. Upside potential exists from LNG export growth and power demand, though valuation appears fair at P/E of 21.7. Key risks include commodity price exposure and high debt levels at $29.7B long-term. The stock offers income stability but limited near-term catalysts given neutral technical positioning.
PHG trades at $26.80, down 0.56% with bearish technical signals. The company shows improved fundamentals with net income turning positive to $895M in 2025 after previous losses, though revenue declined slightly to $17.83B. Analyst consensus is mixed with 40.9% buy ratings but technical indicators show selling pressure. Recent developments include FDA clearances for AI-powered medical devices and strategic healthcare partnerships.
PHG presents a turnaround story with profitability recovery but faces execution risks amid competitive pressures. The stock offers value at reasonable valuations (P/E 23.67, P/S 1.29) but requires monitoring of revenue stabilization and AI product adoption. Near-term catalyst includes Q2 2026 earnings with expected EPS of $0.40.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
